Covalent protein binding is an initial step in dermal contact sensitization. We previously reported the utility of a nitrobenzenethiol (NBT) binding assay for screening thiol reactive haptens (Chipinda et al Chem. Res. Tox. 2010). The present study describes an amine (pyridoxylamine (PDA)) absorbance and fluorescence-based reactivity kinetic probe to complement the NBT assay for identification of amine-selective haptens. Rate constants for 32 chemicals including 5 anhydrides, 6 aldehydes, 2 quinones, among other classes, were determined where reaction times to completion ranged from 20 s to > 2 h. Preliminary assessment suggests labile reactive intermediates are formed during PDA reaction to quinones and benzyl bromide. No reactivity was observed with some thiol-selective sensitizers such as propiolactone or nonsensitizers such as sulfanilamide and benzocaine. Strong correlation (R2 = 0.81) was obtained between PDA reactivity constant (pseudo-first order; k) and the local lymph node assay threshold (EC3) values. Reaction completion time of the sensitizers also correlated strongly (R2 = 0.74) with EC3 values suggesting utility of transforming this chemical reactivity method into a simple, inexpensive end-point assay. The results from the PDA method also highlight the utility of combining this amine based method with the previous NBT based model to be able to identify thiol selective, amine selective and non-selective electrophilic contact allergens.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.